Press Room

Event

54th Organic Process Research and Development Conference (OPR&D)

Start
Monday, September 29, 2025
End
Wednesday, October 01, 2025
Location: Lisbon, Portugal
Booth Number: Table #10

Hovione is exhibiting at the 54th Organic Process Research and Development Conference (OPR&D), a leading Process Chemistry conference that offers a perfect blend between cutting-edge scientific content and networking. Hovione is a proud Gold Sponsor and will join fellow chemists from around the world to exchange ideas, gain fresh insights, and engage in dynamic Q&A and post-presentation discussions. 

Join the Hovione Session 

Wednesday 1 October, 2025 | 9:15 am

  • Title - Integrating Drug Substance Crystallization and Direct Tableting using Spherical Agglomeration: A Model-Driven Approach
  • Speaker - António Henriques, Principal Scientist at Hovione Process Chemistry Development department

Meet the Hovione team in Lisbon – Exclusive R&D Site Visit

As part of the OPR&D Conference, participants can register to attend an exclusive behind-the-scenes tour at the Hovione R&D Center. This is the perfect opportunity to connect with Hovione's Drug Substance Development experts and delve into differentiated chemistry offerings, exploring topics such as spherical agglomeration and micellar chemistry toward more sustainable processes. The interactive session combines lab visits with showcases of Hovione’s latest science.

Please note that availability for this Site Visit is limited, so securing your spot early is highly recommended. Register here.



At Hovione, we specialize in developing and manufacturing complex molecules with built-in sustainability. Our expertise in process chemistry and manufacturing is complemented by our unwavering commitment to rigorous safety and regulatory compliance.

Contact our experts today to bring your complex molecules to commercial success.

 

Schedule a meeting today.

schedule a meeting
https://go.hovione.com/l/47122/2014-08-06/9grc

 

Also in the Press Room

See All

Every year, the largest bank in Portugal, Caixa Geral de Depósitos recognizes some of Portugal’s brightest young minds through the Caixa +Mundo Awards, providing nearly €800,000 in scholarships to students as they pursue higher education. In this year´s edition, Caixa named the award bestowed upon students pursuing science for Diane Villax. This prestigious honor places Diane Villax among the award’s namesakes – a distinguished group of prominent personalities who have made notable contributions to Portugal´s socio-economic, cultural, political and scientific development over the last 50 years, such as António Ramalho Eanes, Mário Soares, José Saramago, Sophia de Mello Breyner, Leonor Beleza, Elvira Fortunato, Rui Nabeiro, Américo Amorim, and José Manuel de Mello. Diane Villax will also honor the seven scientific award winners by personally meeting with each of them, and following their journeys as future innovators and leaders. But this honor is about far more than one individual. It is a celebration of an entire organization and the people behind it. For 67 years, generations of dedicated teams have worked together with passion, purpose, and excellence to manufacture life-saving medicines and advance science that has a real impact on people. This recognition belongs to all of us.    

News

Prestigious Caixa +Mundo Award named in honor of Diane Villax

May 14, 2026

CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing services. The companies partnered in 2023 with plans for development of two capsule-based devices for intranasal delivery: the single-use device and a multidose device. Read the full article at OINDPnews.com      

Press Clipping
OINDP - Orally inhaled and nasal drug products news, May 11, 2026

Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

May 11, 2026

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping
Contract Pharma, 7 May 2026

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026

Also in Events

See All